A New Milestone in LVAD Therapy
For over 30 years, HeartMate™ left ventricular assist devices (LVADs) have led the world in delivering mechanical circulatory support devices to restore blood flow—and life—to patients with advanced heart failure.
The HeartMate 3™ LVAD with Full MagLev™ Flow Technology is a new milestone in LVAD therapy that delivers better blood handling through meaningful innovation.*,**,1
Setting a New Standard for Hemocompatibility
The HeartMate 3™ LVAD addresses the complex interconnectivity of hemocompatibility events by minimizing pump thrombosis without significantly impacting stroke or gastrointestinal bleeding.***
Read more about the Clinical Evidence for HeartMate 3 LVAD.
The HeartMate 3 Left Ventricular Assist System is indicated for providing short-term hemodynamic support (e.g., bridge to transplant or bridge to myocardial recovery) in patients with advanced refractory left ventricular heart failure.
Building comprehensive heart failure management
The HeartMate 3™ LVAD is part of our heart failure management portfolio. Our vision is to transform the treatment of heart failure by designing technology that delivers excellent clinical outcomes and improves workflow and efficiency. Read more about the portfolio and our approach to heart failure management.